Home » Topics » BioWorld Science

BioWorld Science
RSS

Q-State Biosciences enters drug discovery collaboration with Vertex

April 5, 2018

PLA2-R is a potential diagnostic marker of salivary gland tumors

April 5, 2018

Roche acquires Inception neuroscience program from Versant Ventures

April 5, 2018

Phase III REACH-2 study of Cyramza meets primary endpoint

April 5, 2018

FDA and EMA accept regulatory submissions for dacomitinib

April 5, 2018

Novel orally bioavailable rohitukine derivative shows promise in xenograft cancer models

April 5, 2018

Triple combination program for the treatment of cystic fibrosis receives FDA fast track designation

April 5, 2018

Immunic initiates phase III CALDOSE-1 study of IMU-838

April 5, 2018

Phase III study evaluates ASTX-727 versus intravenous decitabine in patients with MDS and CMML

April 5, 2018

Corvus Pharmaceuticals initiates phase I study of CPI-006 in patients with advanced solid tumors

April 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...